Clinical trial
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
NCT06815536 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 16, 2025
- Completion date
- July 31, 2026
- Enrollment
- 2,627 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
neisseria gonorrheae infection